Elidel
formulated to target atopic dermatitis to alleviate skin inflammation.
Strengths: 10 · 30g
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Immunosuppressant
- Pharmacological class
Calcineurin Inhibitor
- Contraindications
hypersensitivity to pimecrolimus; infected skin lesions
- Precautions and warnings
avoid continuous long-term use; minimize sun exposure
- Minor side effects
application site burning; warmth
- Moderate side effects
folliculitis; pruritus
- Serious side effects
anaphylaxis — requires immediate medical attention
- Dosage forms
Cream
- Administration route
Cutaneous use
- Patient summary
formulated to target atopic dermatitis to alleviate skin inflammation.
- Prescription status
POM
- Manufacturer
Meda Pharmaceuticals
- Onset Time
few days
- Duration
as prescribed
- Storage instructions
Store below 25°C.
- Age restrictions
Use in children from 3 months.
- Pregnancy and breastfeeding
Pregnancy: consult doctor. Breastfeeding: consult doctor.
Mechanism of action
This medicine is a calcineurin inhibitor that blocks the activation of T-lymphocytes, preventing the release of inflammatory cytokines in the skin.
Elidel
formulated to target atopic dermatitis to alleviate skin inflammation.
Editorial Notes
- Active ingredient(s): Pimecrolimus
- Listed indication(s): Atopic Dermatitis
Usually available as
- 2 tubes - 10 g1489-10-g-17574
- 2 tubes - 30 g1489-30-g-17725